Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
81 Cards in this Set
- Front
- Back
- 3rd side (hint)
What is a pathogen?
|
Any organism with the potential to cause disease
|
including oppurtunistic pathogens
|
|
Name the 4 kinds of pathogens?
|
bacteria, virus, funghi and parasites?
|
|
|
How can pathogens cause damage?
|
Exotoxin release, Endotoxin release & Direct cytopathic effect.
|
Exotoxin: vibrio cholerae
Endotoxin: Yersinia Pestis Direct cytopathic: influenza virus |
|
Extracellular: Interstitium, blood and lymph.
What is the innate defense mechanism? |
complement, macrophages and neutro's
|
organism: viruses, bacteria, protozoa, funghi, worms.
|
|
What is the innate defense on epithelial surfaces
|
antimicrobial peptides
|
neisseria gonorrhoeae
candida albicans |
|
What is the innate defense against intracellular cytoplasmic infection?
|
NK cells
|
organism: viruses, listeria and protozoa
|
|
What is the innate defense against intracellular vesicular infection?
|
Activated macrophages
|
Organisms: mycobacteria, trypanosomes, Cryptococcus neoformans.
|
|
Innate defense consist of two parts. Name the two parts?
|
Recognition and Effector Cells
|
|
|
Innate defense, two parts
What are the recognition mechanisms? |
Complement and Macrophages
|
|
|
What are complement
|
plasma proteins, especially proteolytic enzymes or proteases
|
made by liver, circulate in inactive forms as zymogens. infection triggers complement activation.
|
|
C3 cascade
|
draw it
|
|
|
What are the three pathways of complement activation
|
Alternative, Lectin and Classical pathway.
|
|
|
function of c3b binding on pathogen surface
|
opsonization, chemotaxis of inflammatory cells and lysis
|
|
|
Why do we need complement control proteins?
|
If not, then due to progressive amplification of C3 cleavage on pathogen surface, depletion of C3
|
|
|
Two kinds of complement control proteins
|
soluble: interacts with c3b on human and microbial surfaces
fixed on membrane proteins: prevention complement fixation at the cell surface. |
|
|
Soluble complement control proteins,
stimulating? |
Properdin (factor P)
|
stabilizes C3Bb on pathogen surface.
|
|
Soluble complement control proteins,
inhibiting? |
Factor H and Factor I
|
Factor H binds on C3b and recruits factor I to cleave C3b into iC3b.
|
|
Membrane Complement control proteins,
Inhibiting |
DAF (decay-accelerating factor)
& MCP (Membrane co-factor protein) |
DAF touches C3bBb and C3b seperates from Bb part.
MCP: seperation, but also factor I recruiment. cleavage to iC3b |
|
strategy Streptococcus pyogenes and stayphylococcus aureus
|
sialic acid expression, mimic human cell, recruits factor H and degrades the bounded C3b.
|
|
|
function complement control proteins
|
discrimination of non-self from self.
protection for depletion |
|
|
first innate effector cell?
|
macrophage
|
in liver: kupffer cells
|
|
how does macrophage recognize the C3b on pathogen surface?
|
CR1 complement receptor 1
|
coating by c3b is calles opsonization.
|
|
function CR1
|
recognition C3b and enhancement macrophage for phagolysosome.
protects against C3b coating on self-cells like DAF and MCP. |
|
|
function CR 3 and 4 (on macrophage.)
|
recogntion of iC3b and LPS.
|
|
|
terminal complement components (lysis)
|
C5-C9
|
|
|
Forming membrane attack complex
|
C3b2Bb + C5-C9
|
|
|
function c5a and c3a
|
chemotaxis with c5a > c3a
|
cave:
as anaphylatoxins, possible anaphylactic shock. |
|
alternative c5 convertase
|
c3b2Bb
|
|
|
protection and regulation of terminal complement components
|
soluble: s protein, clusterin, factor J
Membrane: HRF and CD59 and DAF |
if deficiency in lipid tail of HRF, CD59, DAF, then paroxysmal nocturnal hemoglobinuria.
|
|
function anaphylatoxins c5a and c3a
|
degranulation mast cells, histamines & TNF-alfa.
increase permeability inflammation ;) |
migration monocytes and neutrophils, more plasma proteins as complement.
|
|
plasma proteins that limit the spread of infection
|
coagulation system, kinin system (vasodilation), protease inhibitors as alfa2-macroglobulins.
|
|
|
type receptors on macrophage
|
phagocytic receptors (mannose, CR3, glucan, scavenger receptor)
and receptors promote cytokines secretion. (Toll-Like receptors) |
|
|
TLR endosomes?
|
TLR 3, 7, 8, 9.
|
|
|
TLR1:TLR2 heterodimer
ligands & cells |
lipopeptides
monocytes, dc, eo's baso's mast cells |
bacteria.
|
|
TLR2:TLR6 heterodimer
ligands and cells |
lipoteicoic acid
mono's dc' eo's baso' mast cells |
gram positive bacteria.
|
|
TLR 3
ligands and cells |
Double stranded viral RNA
NK cells |
|
|
TLR 4
ligands and cells |
LPS
Macrophages, DC, Eo's and mast cells |
Gram negative bacteria
|
|
TLR 5
|
Flagellin
Intestinal epithelium |
motile bacteria with flagellum
|
|
TLR 7
|
ssvirRNA
DC, NK, EO's, B cells |
HIV
|
|
TLR8
|
ssvirRNA
NK cells |
Influenza
|
|
TLR 9
|
unmethylated CpG-rich DNA
dc, b cells, eo's baso/s |
bacteria and viruses
|
|
Co-receptors TLR4
|
MD2, CD14
and ligand LPS. |
|
|
two different cytokine response
|
Type 1 interferons: IFN-alfa/beta
& Inflammatory cytokines |
TLR4 is the only one that could use both
|
|
Co-receptors TLR4
|
MD2, CD14
and ligand LPS. |
|
|
Inflammatory cytokines pathway
|
TLR4, MyD88, IRAK4, NFkB,
|
|
|
two different cytokine response
|
Type 1 interferons: IFN-alfa/beta
& Inflammatory cytokines |
TLR4 is the only one that could use both
|
|
Type 1 interferons pathway
|
TLR 4 or 3, IRF 3, IFNalfa/beta
|
|
|
Macrophage secretion inflammatory cytokines due to TLR4
|
IL-1, IL-6, IL8/CXCL8, IL-12 and TNF-alfa
|
|
|
Inflammatory cytokines pathway
|
TLR4, MyD88, IRAK4, NFkB,
|
|
|
inflammatory cytokines
function CXCL8 |
chemokines, attraction via concentration gradient
recruitment neutrophils via CXCR1 and CXCR2 |
|
|
Type 1 interferons pathway
|
TLR 4 or 3, IRF 3, IFNalfa/beta
|
|
|
binding CXCL8 on CXCR1/2 on neutrophils, two effects?
|
it can leave blood and enter tissue
guidance through concentration gradient. |
|
|
Macrophage secretion inflammatory cytokines due to TLR4
|
IL-1, IL-6, IL8/CXCL8, IL-12 and TNF-alfa
|
|
|
inflammatory cytokines
function IL-12 |
activation NK lymphocytes
|
|
|
inflammatory cytokines
function CXCL8 |
chemokines, attraction via concentration gradient
recruitment neutrophils via CXCR1 and CXCR2 |
|
|
inflammatory cytokines
function IL-1, TNF-alfa |
IL-1: activates vascular endothelium, activates lymphocytes, local tissue destruction, production of IL-6 and fever
TNF-alfa: activates vascular endothelium, vascular permeability, increased entry and increase fluid drainage to lymph nodes and fever cave: shock. |
|
|
binding CXCL8 on CXCR1/2 on neutrophils, two effects?
|
it can leave blood and enter tissue
guidance through concentration gradient. |
|
|
Co-receptors TLR4
|
MD2, CD14
and ligand LPS. |
|
|
Inflammatory cytokines
function IL-6 |
fever, induces acute-phase proteind production by hepatocytes.
|
|
|
inflammatory cytokines
function IL-12 |
activation NK lymphocytes
|
|
|
inflammatory cytokines
function IL-1, TNF-alfa |
IL-1: activates vascular endothelium, activates lymphocytes, local tissue destruction, production of IL-6 and fever
TNF-alfa: activates vascular endothelium, vascular permeability, increased entry and increase fluid drainage to lymph nodes and fever cave: shock. |
|
|
two different cytokine response
|
Type 1 interferons: IFN-alfa/beta
& Inflammatory cytokines |
TLR4 is the only one that could use both
|
|
Inflammatory cytokines pathway
|
TLR4, MyD88, IRAK4, NFkB,
|
|
|
Inflammatory cytokines
function IL-6 |
fever, induces acute-phase proteind production by hepatocytes.
|
|
|
Type 1 interferons pathway
|
TLR 4 or 3, IRF 3, IFNalfa/beta
|
|
|
Macrophage secretion inflammatory cytokines due to TLR4
|
IL-1, IL-6, IL8/CXCL8, IL-12 and TNF-alfa
|
|
|
inflammatory cytokines
function CXCL8 |
chemokines, attraction via concentration gradient
recruitment neutrophils via CXCR1 and CXCR2 |
|
|
binding CXCL8 on CXCR1/2 on neutrophils, two effects?
|
it can leave blood and enter tissue
guidance through concentration gradient. |
|
|
inflammatory cytokines
function IL-12 |
activation NK lymphocytes
|
|
|
inflammatory cytokines
function IL-1, TNF-alfa |
IL-1: activates vascular endothelium, activates lymphocytes, local tissue destruction, production of IL-6 and fever
TNF-alfa: activates vascular endothelium, vascular permeability, increased entry and increase fluid drainage to lymph nodes and fever cave: shock. |
|
|
Inflammatory cytokines
function IL-6 |
fever, induces acute-phase proteind production by hepatocytes.
|
|
|
function acute-phase response induced by il-1, il-6 and tnf-alfa.
|
enhance fixation of complement at pathogen surfaces via mannose-binding lectin and CRP.
|
|
|
CRP binding to
|
phosphocholine of LPS, not of human cell membranes.
|
|
|
function crp
|
opsonization and classical pathway.
|
|
|
classical pathway c3 convertase
|
C2aC4b. and at CRP c1 is needed.
|
|
|
reaction of cell when infected by virus
|
production of type 1 interferons
ifnalfa/beta |
|
|
Function IFN-alfa and IFN-beta
|
signaling autocrine and paracrine to induce interferon response
|
|
|
what is interferon repsonse
|
1.degradation of intracellular viral RNA
2. inhibition protein synthesis. 3. increase expression of ligands for receptors on NK cells MIC-A and MIC-B --> NK cells' NKG2D 4. activate NK cells to kill virus-infected cells. |
IFNalfa/beta increase base level cytotoxicity of NK cell and induce proliferation cells.
|
|
What mediators activate NK cells
|
IFNalfa/beta, IL-12 and TNF-alfa
|
|
|
function IFNalfa/beta on NK
|
development of the cells' killer functions
|
|
|
function IL-12 on NK
|
IFN-gamma release to activate macrophage. and then macrophage activates T cell.
so IFN-gamma of NK induces adaptive response. |
IFN-gamma = type 2 interferon.
|